Showing: 1 Results
Trial
Psychiatry

ITI-007-601: A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Lumateperone in the Treatment of Irritability Associated with Autism Spectrum Disorder in Pediatric Patients 5 to 17 Years of Age

Active recruiting

The primary objective is to evaluate the efficacy of high and low doses of lumateperone vs placebo for the

Contact: Oladele Owasoyo 217-545-7231